Last reviewed · How we verify
active control — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
active control (active control) — Shanghai SIMR Biotechnology Co., Ltd.. Active control is a type of comparator used in clinical trials to compare the efficacy of a new treatment.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| active control TARGET | active control | Shanghai SIMR Biotechnology Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- active control CI watch — RSS
- active control CI watch — Atom
- active control CI watch — JSON
- active control alone — RSS
Cite this brief
Drug Landscape (2026). active control — Competitive Intelligence Brief. https://druglandscape.com/ci/active-control. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab